Cargando…

Protein Tau: Prime Cause of Synaptic and Neuronal Degeneration in Alzheimer's Disease

The microtubule-associated protein Tau (MAPT) is a major component of the pathogenesis of a wide variety of brain-damaging disorders, known as tauopathies. These include Alzheimer's disease (AD), denoted as secondary tauopathy because of the obligatory combination with amyloid pathology. In all...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crespo-Biel, Natalia, Theunis, Clara, Van Leuven, Fred
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376502/ https://www.ncbi.nlm.nih.gov/pubmed/22720188 http://dx.doi.org/10.1155/2012/251426

Ejemplares similares

Modeling of Tau-Mediated Synaptic and Neuronal Degeneration in Alzheimer's Disease
por: Jaworski, Tomasz, et al.
Publicado: (2010)

Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
por: Theunis, Clara, et al.
Publicado: (2013)

Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope
por: Theunis, Clara, et al.
Publicado: (2017)

Increasing Brain Protein O-GlcNAc-ylation Mitigates Breathing Defects and Mortality of Tau.P301L Mice
por: Borghgraef, Peter, et al.
Publicado: (2013)

Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice
por: Rat, Dorothea, et al.
Publicado: (2011)

Tau-mediated synaptic damage in Alzheimer’s disease
por: Jadhav, Santosh, et al.
Publicado: (2015)

Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain
por: DeVos, Sarah L., et al.
Publicado: (2018)

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
por: Wu, Moxin, et al.
Publicado: (2021)

Bridging integrator 1 protein loss in Alzheimer’s disease promotes synaptic tau accumulation and disrupts tau release
por: Glennon, Elizabeth B, et al.
Publicado: (2020)

Effects of COVID-19 on Synaptic and Neuronal Degeneration
por: Alqahtani, Mohammed S., et al.
Publicado: (2023)

Dysfunctional Mitochondrial Bioenergetics and Synaptic Degeneration in Alzheimer Disease
por: Tang, Jason, et al.
Publicado: (2019)

Dendritic/Post-synaptic Tau and Early Pathology of Alzheimer’s Disease
por: Yin, Xiaomin, et al.
Publicado: (2021)

Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration
por: Martínez-Maldonado, Alejandra, et al.
Publicado: (2021)

Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer’s continuum
por: Vilor-Tejedor, Natalia, et al.
Publicado: (2021)

Synaptic remodeling of neuronal circuits in early retinal degeneration
por: Soto, Florentina, et al.
Publicado: (2015)

Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration
por: Cortés, Nicole, et al.
Publicado: (2018)

Tau association with synaptic vesicles causes presynaptic dysfunction
por: Zhou, Lujia, et al.
Publicado: (2017)

NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology
por: Rojo, Ana I., et al.
Publicado: (2017)

Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain
por: Kurbatskaya, Ksenia, et al.
Publicado: (2016)

Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration
por: Giannini, Lucia A. A., et al.
Publicado: (2022)

Circuitry and Synaptic Dysfunction in Alzheimer's Disease: A New Tau Hypothesis
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2020)

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
por: Milà‐Alomà, Marta, et al.
Publicado: (2020)

Correction to: Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration
por: Giannini, Lucia A. A., et al.
Publicado: (2023)

Silver nanoparticles (AgNPs) cause degeneration of cytoskeleton and disrupt synaptic machinery of cultured cortical neurons
por: Xu, Fenglian, et al.
Publicado: (2013)

Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies
por: Dujardin, Simon, et al.
Publicado: (2014)

White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease
por: Tian, Jianqiao, et al.
Publicado: (2023)

Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2020)

Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
por: Vogel, Jacob W., et al.
Publicado: (2020)

GSK3 and Alzheimer’s Disease: Facts and Fiction…
por: Kremer, Anna, et al.
Publicado: (2011)

Evidence that the presynaptic vesicle protein CSPalpha is a key player in synaptic degeneration and protection in Alzheimer’s disease
por: Tiwari, Sachin S, et al.
Publicado: (2015)

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
por: Janelidze, Shorena, et al.
Publicado: (2020)

Dysregulated Neurotransmission induces Trans-synaptic degeneration in reconstructed Neuronal Networks
por: Deleglise, Bérangère, et al.
Publicado: (2018)

Granulovacuolar degeneration bodies: red alert for neurons with MAPT/tau pathology
por: Wiersma, Vera I., et al.
Publicado: (2019)

Synaptic and metabolic gene expression alterations in neurons that are recipients of proteopathic tau seeds
por: Perez-Rando, Marta, et al.
Publicado: (2020)

Fukutin regulates tau phosphorylation and synaptic function: Novel properties of fukutin in neurons
por: Tsukui, Ryota, et al.
Publicado: (2022)

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
por: Hellwig, Konstantin, et al.
Publicado: (2015)

β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer’s disease
por: Mohaupt, Pablo, et al.
Publicado: (2022)

Munc18-1 binding to the neuronal SNARE complex controls synaptic vesicle priming
por: Deák, Ferenc, et al.
Publicado: (2009)

Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
por: Sanchez-Mejias, Elisabeth, et al.
Publicado: (2016)

Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathology
por: Hou, Xu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ao2nmk9ifpeud0asie8midtes0